Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Clinical trial NCT05806814 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05806814
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-12
- Primary completion
- 2026-05-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.